DOACs May Increase Risk of Bleeding Complications in Severe COVID-19 Cases
Replacing DOACs with alternative parenteral antithrombotic strategies may help to prevent bleeding complications in patients with SARS-CoV-2 infection.
Replacing DOACs with alternative parenteral antithrombotic strategies may help to prevent bleeding complications in patients with SARS-CoV-2 infection.
Patients undergoing allogeneic hematopoietic cell transplantation who have greater intestinal microbiota diversity may have a lower risk for mortality.